Baxter's Alzheimer's disease drug fails in late-stage trial
(Reuters) - Baxter International Inc said it will stop developing a drug for treating mild to moderate Alzheimer's disease after a late-stage study sh...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/xMfjlC0o11U/story01.htm
No comments:
Post a Comment